MRGPRF
gene geneOn this page
Also known as MGC21621mrgF
Summary
MRGPRF (MAS related GPR family member F, HGNC:24828) is a protein-coding gene on chromosome 11q13.3, encoding Mas-related G-protein coupled receptor member F (Q96AM1). Orphan receptor.
Predicted to enable G protein-coupled receptor activity. Predicted to be involved in G protein-coupled receptor signaling pathway. Located in nuclear membrane; nucleoplasm; and plasma membrane.
Source: NCBI Gene 116535 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 75 total
- Druggable target: yes
- MANE Select transcript:
NM_145015
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24828 |
| Approved symbol | MRGPRF |
| Name | MAS related GPR family member F |
| Location | 11q13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC21621, mrgF |
| Ensembl gene | ENSG00000172935 |
| Ensembl biotype | protein_coding |
| OMIM | 607233 |
| Entrez | 116535 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 10 protein_coding
ENST00000309099, ENST00000320913, ENST00000885480, ENST00000885481, ENST00000885482, ENST00000885483, ENST00000885484, ENST00000885485, ENST00000925381, ENST00000964385
RefSeq mRNA: 2 — MANE Select: NM_145015
NM_001098515, NM_145015
CCDS: CCDS8188
Canonical transcript exons
ENST00000309099 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001241938 | 69004398 | 69006261 |
| ENSE00001387845 | 69009854 | 69009957 |
| ENSE00002243872 | 69013083 | 69013246 |
Expression profiles
Bgee: expression breadth ubiquitous, 214 present calls, max score 98.64.
FANTOM5 (CAGE): breadth broad, TPM avg 8.0469 / max 204.5209, expressed in 873 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 121023 | 6.0081 | 840 |
| 121022 | 1.7531 | 552 |
| 121024 | 0.2857 | 179 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of stomach | UBERON:0001199 | 98.64 | gold quality |
| left uterine tube | UBERON:0001303 | 98.14 | gold quality |
| saphenous vein | UBERON:0007318 | 97.77 | gold quality |
| body of uterus | UBERON:0009853 | 97.73 | gold quality |
| urethra | UBERON:0000057 | 97.58 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 97.27 | gold quality |
| myometrium | UBERON:0001296 | 97.10 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 96.99 | gold quality |
| cauda epididymis | UBERON:0004360 | 96.96 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 96.89 | gold quality |
| endocervix | UBERON:0000458 | 96.87 | gold quality |
| lower esophagus | UBERON:0013473 | 96.82 | gold quality |
| nipple | UBERON:0002030 | 96.52 | gold quality |
| popliteal artery | UBERON:0002250 | 95.98 | gold quality |
| tibial artery | UBERON:0007610 | 95.97 | gold quality |
| aorta | UBERON:0000947 | 95.89 | gold quality |
| right coronary artery | UBERON:0001625 | 95.86 | gold quality |
| thoracic aorta | UBERON:0001515 | 95.82 | gold quality |
| ascending aorta | UBERON:0001496 | 95.72 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 95.48 | gold quality |
| pericardium | UBERON:0002407 | 94.98 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 94.74 | gold quality |
| ectocervix | UBERON:0012249 | 94.53 | gold quality |
| vena cava | UBERON:0004087 | 94.48 | gold quality |
| left coronary artery | UBERON:0001626 | 93.94 | gold quality |
| coronary artery | UBERON:0001621 | 93.78 | gold quality |
| seminal vesicle | UBERON:0000998 | 93.07 | gold quality |
| uterine cervix | UBERON:0000002 | 92.78 | gold quality |
| penis | UBERON:0000989 | 91.99 | gold quality |
| right ovary | UBERON:0002118 | 91.96 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-10 | yes | 19.04 |
| E-ANND-3 | yes | 9.03 |
| E-HCAD-11 | yes | 7.89 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): HBP1, HIF1A, HOXB2, JUN, SP1, TBX10, ZGPAT
miRNA regulators (miRDB)
37 targeting MRGPRF, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-6875-3P | 99.82 | 70.26 | 2983 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-6764-5P | 99.75 | 67.89 | 2304 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-6766-5P | 99.68 | 67.70 | 2325 |
| HSA-MIR-1915-3P | 99.58 | 66.79 | 1988 |
| HSA-MIR-1207-5P | 99.49 | 69.11 | 2983 |
| HSA-MIR-6081 | 99.48 | 66.07 | 1446 |
| HSA-MIR-3182 | 99.40 | 68.15 | 2454 |
| HSA-MIR-5580-5P | 99.38 | 66.96 | 1139 |
| HSA-MIR-4505 | 99.27 | 67.81 | 2678 |
| HSA-MIR-5787 | 99.22 | 67.86 | 2628 |
| HSA-MIR-485-5P | 99.10 | 64.78 | 1889 |
| HSA-MIR-6884-5P | 99.10 | 64.50 | 1987 |
| HSA-MIR-4763-3P | 99.10 | 67.83 | 2649 |
| HSA-MIR-511-5P | 98.97 | 70.94 | 2268 |
| HSA-MIR-6846-5P | 98.81 | 65.86 | 1121 |
| HSA-MIR-6848-5P | 98.81 | 65.49 | 1126 |
| HSA-MIR-1178-3P | 98.57 | 67.09 | 890 |
| HSA-MIR-518C-5P | 98.53 | 69.20 | 1640 |
| HSA-MIR-4468 | 98.01 | 66.85 | 1187 |
| HSA-MIR-6748-3P | 97.20 | 65.66 | 836 |
| HSA-MIR-939-5P | 97.10 | 65.80 | 1579 |
| HSA-MIR-505-5P | 97.01 | 65.54 | 778 |
| HSA-MIR-3059-3P | 96.71 | 67.08 | 606 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Mrgprf | ENSMUSG00000031070 |
| rattus_norvegicus | Mrgprf | ENSRNOG00000013426 |
Paralogs (10): MAS1 (ENSG00000130368), MRGPRX1 (ENSG00000170255), MRGPRD (ENSG00000172938), GPR152 (ENSG00000175514), MRGPRX4 (ENSG00000179817), MRGPRX3 (ENSG00000179826), MRGPRG (ENSG00000182170), MRGPRX2 (ENSG00000183695), MRGPRE (ENSG00000184350), MAS1L (ENSG00000204687)
Protein
Protein identifiers
Mas-related G-protein coupled receptor member F — Q96AM1 (reviewed: Q96AM1)
Alternative names: G-protein coupled receptor 140, G-protein coupled receptor 168
All UniProt accessions (2): Q96AM1, F5H5R4
UniProt curated annotations — full annotation on UniProt →
Function. Orphan receptor. May bind to a neuropeptide and may regulate nociceptor function and/or development, including the sensation or modulation of pain.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family. Mas subfamily.
RefSeq proteins (2): NP_001091985, NP_659452* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR026228 | MRGPCRF | Family |
| IPR026234 | MRGPCRFAMILY | Family |
Pfam: PF00001
UniProt features (19 total): topological domain 8, transmembrane region 7, chain 1, region of interest 1, glycosylation site 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96AM1-F1 | 80.58 | 0.52 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 4
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 96 (showing top):
GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_UP, RNGTGGGC_UNKNOWN, AP1_01, FREAC2_01, WWTAAGGC_UNKNOWN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, CHANDRAN_METASTASIS_DN, chr11q13, CAGCTG_AP4_Q5, MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, SRF_Q5_01, CREB_Q4, SRF_C, FREAC3_01, HEN1_01
GO Biological Process (2): G protein-coupled receptor signaling pathway (GO:0007186), signal transduction (GO:0007165)
GO Molecular Function (1): G protein-coupled receptor activity (GO:0004930)
GO Cellular Component (5): nucleoplasm (GO:0005654), plasma membrane (GO:0005886), nuclear membrane (GO:0031965), ciliary transition zone (GO:0035869), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| nuclear lumen | 1 |
| membrane | 1 |
| cell periphery | 1 |
| nucleus | 1 |
| nuclear envelope | 1 |
| organelle membrane | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
832 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MRGPRF | NPFF | O15130 | 822 |
| MRGPRF | OR7C2 | O60412 | 507 |
| MRGPRF | COPZ2 | Q9P299 | 458 |
| MRGPRF | ZDHHC13 | Q8IUH4 | 441 |
| MRGPRF | OR5C1 | Q8NGR4 | 440 |
| MRGPRF | MYEOV | Q96EZ4 | 435 |
| MRGPRF | VGLL3 | A8MV65 | 422 |
| MRGPRF | ATOH8 | Q96SQ7 | 421 |
| MRGPRF | PRRX2 | Q99811 | 415 |
| MRGPRF | EFEMP2 | O95967 | 402 |
| MRGPRF | GRM3 | Q14832 | 399 |
| MRGPRF | FKBP10 | Q96AY3 | 398 |
| MRGPRF | COL16A1 | Q07092 | 398 |
| MRGPRF | COL1A2 | P02464 | 388 |
| MRGPRF | TGFB1I1 | O43294 | 388 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MRGPRF | RAMP3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ESYT2 | psi-mi:“MI:0914”(association) | 0.350 | |
| E5 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (8): MRGPRF (Affinity Capture-MS), MRGPRF (Affinity Capture-MS), MRGPRF (Affinity Capture-MS), MRGPRF (Affinity Capture-MS), USP45 (Affinity Capture-Western), MRGPRF (Affinity Capture-Western), MRGPRF (PCA), MRGPRF (Reconstituted Complex)
ESM2 similar proteins: P04201, P12526, P23749, P30554, P35410, P59534, P59535, Q3KNA1, Q3UG50, Q3UG61, Q4VHE7, Q645S5, Q645U4, Q645Y7, Q645Y8, Q645Y9, Q646A9, Q646B0, Q646C8, Q646D3, Q646F0, Q646F1, Q67ER9, Q67ES7, Q67ET0, Q67ET2, Q7TN38, Q7TN41, Q7TN44, Q7TN51, Q7TQA5, Q7TQA6, Q7TQB8, Q8CIP3, Q8R4G1, Q8TDS7, Q8VCJ6, Q91WW2, Q91WW3, Q91ZB8
Diamond homologs: B9VR26, O55197, O88680, P04201, P12526, P23749, P30554, P35410, Q16581, Q2LL16, Q3KNA1, Q3UG50, Q3UG61, Q4QXU0, Q4QXU2, Q4QXU3, Q4QXU4, Q4QXU5, Q4QXU6, Q4QXX9, Q5REI5, Q5U9D9, Q6L786, Q6TAC8, Q6XKD3, Q7TN38, Q7TN39, Q7TN40, Q7TN41, Q7TN44, Q7TN45, Q7TN49, Q7TN50, Q7TN51, Q86SM5, Q8CIP3, Q8NGA4, Q8R4G1, Q8TDS7, Q8VCJ6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
75 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 66 |
| Likely benign | 2 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
459 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:69006257:CACAT:C | acceptor_gain | 1.0000 |
| 11:69006259:CAT:C | acceptor_gain | 1.0000 |
| 11:69006262:CT:C | acceptor_loss | 1.0000 |
| 11:69009953:CCCAC:C | acceptor_gain | 1.0000 |
| 11:69009954:CCACC:C | acceptor_gain | 1.0000 |
| 11:69009956:ACCTG:A | acceptor_loss | 1.0000 |
| 11:69009958:C:CA | acceptor_loss | 1.0000 |
| 11:69006258:ACAT:A | acceptor_gain | 0.9900 |
| 11:69006259:CATC:C | acceptor_gain | 0.9900 |
| 11:69006260:AT:A | acceptor_gain | 0.9900 |
| 11:69006262:C:CC | acceptor_gain | 0.9900 |
| 11:69006265:C:CT | acceptor_gain | 0.9900 |
| 11:69006267:CAGG:C | acceptor_gain | 0.9900 |
| 11:69006270:G:C | acceptor_gain | 0.9900 |
| 11:69006270:G:GC | acceptor_gain | 0.9900 |
| 11:69009849:CTTA:C | donor_loss | 0.9900 |
| 11:69009850:TTACC:T | donor_loss | 0.9900 |
| 11:69009851:TA:T | donor_loss | 0.9900 |
| 11:69009852:ACC:A | donor_loss | 0.9900 |
| 11:69009955:CAC:C | acceptor_gain | 0.9900 |
| 11:69009962:C:CT | acceptor_gain | 0.9900 |
| 11:69009963:A:T | acceptor_gain | 0.9900 |
| 11:69009970:C:CT | acceptor_gain | 0.9900 |
| 11:69012412:A:AC | donor_gain | 0.9900 |
| 11:69012413:C:CC | donor_gain | 0.9900 |
| 11:69013078:GCTAC:G | donor_loss | 0.9900 |
| 11:69013079:CTACC:C | donor_loss | 0.9900 |
| 11:69013080:TACCT:T | donor_loss | 0.9900 |
| 11:69013081:ACCT:A | donor_loss | 0.9900 |
| 11:69013082:C:G | donor_loss | 0.9900 |
AlphaMissense
2221 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:69005426:C:T | G295E | 0.989 |
| 11:69006138:C:G | G58R | 0.988 |
| 11:69005375:C:G | R312P | 0.987 |
| 11:69005447:G:C | P288R | 0.986 |
| 11:69005447:G:T | P288H | 0.986 |
| 11:69005475:A:G | C279R | 0.986 |
| 11:69005808:A:G | W168R | 0.986 |
| 11:69005808:A:T | W168R | 0.986 |
| 11:69005439:A:C | Y291D | 0.984 |
| 11:69005455:G:C | S285R | 0.984 |
| 11:69005455:G:T | S285R | 0.984 |
| 11:69005457:T:G | S285R | 0.984 |
| 11:69005566:G:C | F248L | 0.984 |
| 11:69005566:G:T | F248L | 0.984 |
| 11:69005568:A:G | F248L | 0.984 |
| 11:69006147:A:G | C55R | 0.984 |
| 11:69005441:A:T | V290D | 0.983 |
| 11:69006025:G:C | S95R | 0.983 |
| 11:69006025:G:T | S95R | 0.983 |
| 11:69006027:T:G | S95R | 0.983 |
| 11:69006137:C:T | G58D | 0.983 |
| 11:69005427:C:G | G295R | 0.981 |
| 11:69005427:C:T | G295R | 0.981 |
| 11:69005453:G:T | A286D | 0.981 |
| 11:69005469:A:G | C281R | 0.981 |
| 11:69005896:G:C | S138R | 0.981 |
| 11:69005896:G:T | S138R | 0.981 |
| 11:69005898:T:G | S138R | 0.981 |
| 11:69006124:G:C | N62K | 0.981 |
| 11:69006124:G:T | N62K | 0.981 |
dbSNP variants (sampled 300 via entrez): RS1000005074 (11:69014742 G>A,T), RS1000439978 (11:69015004 A>G), RS1000737094 (11:69012962 C>T), RS1000849518 (11:69011059 G>C), RS1001530743 (11:69008675 G>A,C), RS1001563367 (11:69008934 A>T), RS1002094691 (11:69013588 C>T), RS1002137097 (11:69007559 A>T), RS1002170229 (11:69011932 C>A,T), RS1002836416 (11:69013924 C>A,T), RS1003238970 (11:69007706 T>G), RS1003367817 (11:69012683 A>T), RS1003407068 (11:69008848 G>A), RS1003846107 (11:69008618 C>T), RS1004247755 (11:69009134 G>A)
Disease associations
OMIM: gene MIM:607233 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4523903 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Class A Orphans with no pharmacology
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, decreases expression, increases methylation | 4 |
| entinostat | increases expression, affects cotreatment | 2 |
| Phenylmercuric Acetate | affects cotreatment, increases expression | 2 |
| methylmercuric chloride | increases expression | 1 |
| pirinixic acid | increases expression, affects binding, increases activity | 1 |
| sodium arsenite | increases expression, increases abundance | 1 |
| mercuric bromide | increases expression, affects cotreatment | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Carbamazepine | affects expression | 1 |
| Dexamethasone | increases expression | 1 |
| Estradiol | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Triclosan | decreases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
ChEMBL screening assays
2 unique, capped per target: 2 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4883533 | Binding | PRESTO-Tango GPCRome screening (MRGPRF) | Data for DCP probe UCSF924 |
Cellosaurus cell lines
1 cell lines: 1 spontaneously immortalized cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_KY47 | PathHunter CHO-K1 MRGPRF beta-arrestin | Spontaneously immortalized cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.